Cargando…
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
As a novel discovered regulated cell death pattern, ferroptosis has been associated with the development of Parkinson’s disease (PD) and has attracted widespread attention. Nevertheless, the relationship between ferroptosis and PD pathogenesis is still unclear. This study aims to investigate the eff...
Autores principales: | Zeng, Xiaoyan, An, Hedi, Yu, Fei, Wang, Kai, Zheng, Lanlan, Zhou, Wei, Bao, Yiwen, Yang, Jie, Shen, Nan, Huang, Dongya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053182/ https://www.ncbi.nlm.nih.gov/pubmed/33646533 http://dx.doi.org/10.1007/s11064-021-03262-9 |
Ejemplares similares
-
Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012) -
Parkinson’s Disease Gene Biomarkers Screened by the LASSO and SVM Algorithms
por: Bao, Yiwen, et al.
Publicado: (2023) -
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015) -
New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019) -
Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)